Please login to the form below

Not currently logged in


This page shows the latest ivermectin news and features for those working in and with pharma, biotech and healthcare.

Oxford University to study antiparasitic drug ivermectin in COVID-19 trial

Oxford University to study antiparasitic drug ivermectin in COVID-19 trial

Researchers from the University of Oxford are planning to investigate the antiparasitic drug ivermectin as part of the PRINCIPLE trial – a large-scale clinical trial evaluating possible at-home COVID-19 ... treatments. In lab studies, ivermectin has

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....